Fosfomycin Sodium Market Scope
Fosfomycin is a phosphoenolpyruvate analog and a synthetic broad-spectrum antibiotic with antimicrobial and bactericidal properties. Fosfomycin binds to the enzyme enol pyruvate transferase and inactivates it. This leads to an irreversible blocking of the condensation of uridine diphosphate-N-acetylglucosamine with p-enol pyruvate, which is one of the first steps in bacterial cell wall synthesis and ultimately leads to cell lysis and bacterial cell death. Fosfomycin is an orally available broad-spectrum antibiotic that is mainly used to treat uncomplicated urinary tract infections. Fosfomycin is associated with jaundice with a low rate of transient serum enzymes during therapy and with rare cases of clinically apparent acute liver damage.
The market study is being classified by Type (Tablets and Injection), by Application (Common Urinary Tract Infection, Postoperative Urinary Tract Infection and Preoperative Prevention of Urinary Tract Infection) and major geographies with country level break-up.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Asian Players will contribute to the maximum growth of Global Fosfomycin Sodium market throughout the predicted period.
Merck Group (Germany), AdvaCare Pharma (United States), LGM Pharma (United States), Cipla (India), Northeast Pharmaceutical Group Co. Ltd. (China), Ercros (Spain), SGPharma Pvt. Ltd. (India), Shin Poong Pharm Co. Ltd. (South Korea), Sundent Pharm Group (China) and Hubei Xunda Pharmaceutical (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are FarmaSino Pharmaceutical (China) and National Analytical Corporation (India).
AdvanceMarketAnalytics has segmented the market of Global Fosfomycin Sodium market by Type, Application and Region.
On the basis of geography, the market of Fosfomycin Sodium has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
On, April 2, 2019, Merck had completed the acquisition of Immune Design. Merck is a leading global biopharmaceutical company of the United States and Canada, it has been inventing for life, bringing forward medicines and vaccines for many of the world’s most highly challenging diseases.
- Increasing Healthcare Spending and Demand for Drug Therapy
- Growing Geriatric Population in Major Economies
- Growing Cases of Urinary Tract Infections
- Increase in the Unhygienic Conditions of Toilets
- R&D and Product Innovation
- Potential Growth From Emerging Countries
- Stringent Government Rules and Regulation
- Side Effects Due to Fosfomycin Sodium
- Availability of Substitute Drugs in the Market
Key Target AudienceManufacturers of Fosfomycin Sodium, Suppliers and Distributors of Fosfomycin Sodium, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase